UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 238

Sortiert nach

HLA genotype and cortical lesions: Response to the letter from Spencer et al

Multiple sclerosis, 2018-05, Vol.24 (6), p.819-820

2018

Volltextzugriff (PDF)

Brain gray matter astroglia-specific connexin 43 ablation attenuates spinal cord inflammatory demyelination

Journal of neuroinflammation, 2021-06, Vol.18 (1), p.126-126, Article 126

2021

Volltextzugriff (PDF)

HLA-DRB104:05 allele is associated with intracortical lesions on three-dimensional double inversion recovery images in Japanese patients with multiple sclerosis

Multiple sclerosis, 2018-05, Vol.24 (6), p.710-720

2018

Volltextzugriff (PDF)

Long-term use of interferon-β in multiple sclerosis increases Vδ1 - Vδ2 - Vγ9 - γδ T cells that are associated with a better outcome

Journal of neuroinflammation, 2019-09, Vol.16 (1), p.179-179, Article 179

2019

Volltextzugriff (PDF)

Contribution of cortical lesions to cognitive impairment in Japanese patients with multiple sclerosis

Scientific reports, 2020-03, Vol.10 (1), p.5228-5228, Article 5228

2020

Volltextzugriff (PDF)

Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age

EBioMedicine, 2022-08, Vol.82, p.104179-104179, Article 104179

2022

Volltextzugriff (PDF)

A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression

Journal of neuroinflammation, 2018-09, Vol.15 (1), p.255-255, Article 255

2018

Volltextzugriff (PDF)

Environmental risk factors for multiple sclerosis in Japanese people

Multiple sclerosis and related disorders, 2020-02, Vol.38, p.101872, Article 101872

2020

Volltextzugriff (PDF)

A case of overlapping adult‐onset linear scleroderma and Parry‐Romberg syndrome presenting with widespread ipsilateral neurogenic involvement

Neuropathology, 2020-02, Vol.40 (1), p.109-115

2020

Volltextzugriff (PDF)

Association of Decreased Percentage of Vδ2 + Vγ9 + γδ T Cells With Disease Severity in Multiple Sclerosis

Frontiers in immunology, 2018-04, Vol.9, p.748-748

2018

Volltextzugriff (PDF)

CD30 ligand is a new therapeutic target for central nervous system autoimmunity

Journal of autoimmunity, 2015-02, Vol.57, p.14-23

2015

Volltextzugriff (PDF)

CD30 ligand could be a new therapeutic target for central nervous system autoimmunity

Clinical & experimental neuroimmunology, 2015-05, Vol.6 (2), p.111-112

2015

Volltextzugriff (PDF)

Creutzfeldt–Jakob disease‐like diffusion‐weighted imaging hyperintensity paralleled with neuropsychiatric symptoms in a patient with limbic encephalitis associated with anti‐voltage‐gated potassium channel complex antibodies

Clinical & experimental neuroimmunology, 2019-08, Vol.10 (3), p.204-206

2019

Volltextzugriff (PDF)

Peripheral blood T cell subset characteristics of multiple sclerosis in remission phase correlate with annualized relapse rates

Clinical & experimental neuroimmunology, 2016-11, Vol.7 (4), p.346-352

2016

Volltextzugriff (PDF)

Long-Term Physical Stability of Amorphous Solid Dispersions: Comparison of Detection Powers of Common Evaluation Methods for Spray-Dried and Hot-Melt Extruded Formulations

Journal of pharmaceutical sciences, 2024-06

2024

Volltextzugriff (PDF)

The 32nd European Committee for Treatment and Research in Multiple Sclerosis

Clinical & experimental neuroimmunology, 2017-02, Vol.8 (1), p.82-85

2017

Volltextzugriff (PDF)

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity

Proceedings of the National Academy of Sciences - PNAS, 2023-01, Vol.120 (3), p.e2207291120-e2207291120

2023

Volltextzugriff (PDF)

Clinical Application of a New Compact Computed Tomography System for Evaluating the Outcome of Regenerative Therapy: A Case Report

Journal of periodontology (1970), 2001-05, Vol.72 (5), p.696-702

2001

Volltextzugriff (PDF)

CD 30 ligand could be a new therapeutic target for central nervous system autoimmunity

Clinical & experimental neuroimmunology, 2015-05, Vol.6 (2), p.111-112

2015

Volltextzugriff (PDF)

Central nervous system-specific antinuclear antibodies in patients with multiple sclerosis

Journal of the neurological sciences, 2020-02, Vol.409, p.116619-116619, Article 116619

2020

Volltextzugriff (PDF)

Risk HLA-DRB1 alleles differentially influence brain and lesion volumes in Japanese patients with multiple sclerosis

Journal of the neurological sciences, 2020-06, Vol.413, p.116768-116768, Article 116768

2020

Volltextzugriff (PDF)

Long-term use of interferon-[beta] in multiple sclerosis increases V[delta]1-V[delta]2-V[gamma]9- [gamma][delta] T cells that are associated with a better outcome

Journal of neuroinflammation, 2019-09, Vol.16 (1)

2019

Volltextzugriff (PDF)

Abnormal B-Cell and Tfh-Cell Profiles in Patients With Parkinson Disease: A Cross-sectional Study

Neurology : neuroimmunology & neuroinflammation, 2022-03, Vol.9 (2)

2022

Volltextzugriff (PDF)

Requirement of CD30 expression on CD4 T cells in the pathogenesis of experimental autoimmune encephalomyelitis

Journal of neuroimmunology, 2016-02, Vol.291, p.39-45

2016

Volltextzugriff (PDF)

Re-emergence of a tumefactive demyelinating lesion after initiation of fingolimod therapy

Journal of the neurological sciences, 2017-08, Vol.379, p.167-168

2017

Volltextzugriff (PDF)

1 – 25 von 238

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(181)
Mit Volltextzugriff
(226)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

HLA genotype and cortical lesions: Response to the letter from Spencer et al

Brain gray matter astroglia-specific connexin 43 ablation attenuates spinal cord inflammatory demyelination

HLA-DRB104:05 allele is associated with intracortical lesions on three-dimensional double inversion recovery images in Japanese patients with multiple sclerosis

Long-term use of interferon-β in multiple sclerosis increases Vδ1 - Vδ2 - Vγ9 - γδ T cells that are associated with a better outcome

Contribution of cortical lesions to cognitive impairment in Japanese patients with multiple sclerosis

Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age

A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression

Environmental risk factors for multiple sclerosis in Japanese people

A case of overlapping adult‐onset linear scleroderma and Parry‐Romberg syndrome presenting with widespread ipsilateral neurogenic involvement

Association of Decreased Percentage of Vδ2 + Vγ9 + γδ T Cells With Disease Severity in Multiple Sclerosis

CD30 ligand is a new therapeutic target for central nervous system autoimmunity

CD30 ligand could be a new therapeutic target for central nervous system autoimmunity

Creutzfeldt–Jakob disease‐like diffusion‐weighted imaging hyperintensity paralleled with neuropsychiatric symptoms in a patient with limbic encephalitis associated with anti‐voltage‐gated potassium channel complex antibodies

Peripheral blood T cell subset characteristics of multiple sclerosis in remission phase correlate with annualized relapse rates

Long-Term Physical Stability of Amorphous Solid Dispersions: Comparison of Detection Powers of Common Evaluation Methods for Spray-Dried and Hot-Melt Extruded Formulations

The 32nd European Committee for Treatment and Research in Multiple Sclerosis

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity

Clinical Application of a New Compact Computed Tomography System for Evaluating the Outcome of Regenerative Therapy: A Case Report

CD 30 ligand could be a new therapeutic target for central nervous system autoimmunity

Central nervous system-specific antinuclear antibodies in patients with multiple sclerosis

Risk HLA-DRB1 alleles differentially influence brain and lesion volumes in Japanese patients with multiple sclerosis

Long-term use of interferon-[beta] in multiple sclerosis increases V[delta]1-V[delta]2-V[gamma]9- [gamma][delta] T cells that are associated with a better outcome

Abnormal B-Cell and Tfh-Cell Profiles in Patients With Parkinson Disease: A Cross-sectional Study

Requirement of CD30 expression on CD4 T cells in the pathogenesis of experimental autoimmune encephalomyelitis

Re-emergence of a tumefactive demyelinating lesion after initiation of fingolimod therapy

Suchergebnisse filtern